Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 4, 2009, Pages

  Wang, Fang ^a   Kim, Min Suk ^a   Puthanveetil, Prasanth ^a   Kewalramani, Girish ^a   Deppe, Sylvia ^a   Ghosh, Sanjoy ^a   Abrahani, Ashraf ^a   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cytoskeleton; Diabetes; Diazoxide; Endothelial cell; High glucose

Indexed keywords

CYTOCHALASIN D; DIAZOXIDE; FATTY ACID; GLUCOSE; HEPARANASE; INSULIN; NOCODAZOLE; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; HEART MUSCLE CELL; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN BLOOD LEVEL; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELLS, CULTURED; CYTOCHALASIN D; CYTOSKELETON; DIAZOXIDE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FATTY ACIDS; GLUCOSE; GLUCURONIDASE; HYPERGLYCEMIA; INSULIN; LIPOPROTEIN LIPASE; MALE; MYOCYTES, CARDIAC; NOCODAZOLE; PALMITIC ACID; RATS; RATS, WISTAR; TUBULIN MODULATORS;

EID: 66249120371     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01312.2008     Document Type: Article

References (39)

1. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291: H1489-H1506, 2006.
2. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, Vigorito C, Sacca L, Toffolo G, Cobelli C, Trevisan R, Duner E, Razzolini R, Rengo F, Crepaldi G. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease Am J Physiol Endocrinol Metab 258: E606-E618, 1990.
3. Blanchette-Mackie EJ, Dwyer NK, Amende LA. Cytochemical studies of lipid metabolism: immunogold probes for lipoprotein lipase and cholesterol. Am J Anat 185: 255-263, 1989.
4. Blanchette-Mackie EJ, Masuno H, Dwyer NK, Olivecrona T, Scow RO. Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiol Endocrinol Metab 256: E818 -E828, 1989.
5. Blott EJ, Griffiths GM. Secretory lysosomes. Nat Rev Mol Cell Biol 3: 122-131, 2002.
6. Camps L, Reina M, Llobera M, Vilaro S, Olivecrona T. Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol Cell Physiol 258: C673-C681, 1990.
7. Chen G, Wang D, Vikramadithyan R, Yagyu H, Saxena U, Pillarisetti S, Goldberg IJ. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry 43: 4971-4977, 2004.
8. De Deckere EA, Ten Hoor P. A modified Langendorff technique for metabolic investigations. Pflügers Arch 370: 103-105, 1977.
9. de Lannoy LM, Danser AH, van Kats JP, Schoemaker RG, Saxena PR, Schalekamp MA. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension 29: 1240-1251, 1997.
10. DuBose DA, Haugland R. Comparisons of endothelial cell G- and F-actin distribution in situ and in vitro. Biotech Histochem 68: 8-16, 1993.
11. Eckel RH. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320: 1060-1068, 1989.
12. Fedarko NS, Conrad HE. A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. J Cell Biol 102: 587-599, 1986.
13. Gingis-Velitski S, Zetser A, Kaplan V, Ben-Zaken O, Cohen E, Levy-Adam F, Bashenko Y, Flugelman MY, Vlodavsky I, Ilan N. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J Biol Chem 279: 44084-44092, 2004.
14. Haffner SM. Lipoprotein disorders associated with type 2 diabetes mel- litus and insulin resistance. Am J Cardiol 90: 55i-61i, 2002.
15. Jansen H, Stam H, Kalkman C, Hulsmann WC. On the dual localization of lipoprotein lipase in rat heart. Studies with a modified perfusion technique. Biochem Biophys Res Commun 92: 411-416, 1980.
16. Kim MS, Kewalramani G, Puthanveetil P, Lee V, Kumar U, An D, Abrahani A, Rodrigues B. Acute diabetes moderates trafficking of cardiac lipoprotein lipase through p38 mitogen-activated protein kinase- dependent actin cytoskeleton organization. Diabetes 57: 64 -76, 2008.
17. Kim MS, Wang F, Puthanveetil P, Kewalramani G, Hosseini-Beheshti E, Ng N, Wang Y, Kumar U, Innis S, Proud CG, Abrahani A, Rodrigues B. Protein kinase D is a key regulator of cardiomyocyte lipoprotein lipase secretion after diabetes. Circ Res 103: 252-260, 2008.
18. Levak-Frank S, Radner H, Walsh A, Stollberger R, Knipping G, Hoefler G, Sattler W, Weinstock PH, Breslow JL, Zechner R. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in trans- genic mice. J Clin Invest 96: 976-986, 1995.
19. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994.
20. Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D Jr, Gattuso P, Schwartz MM, Lewis EJ, Prinz RA, Xu X. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 54: 2172-2178, 2005.
21. McKenzie EA. Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 151: 1-14, 2007.
22. Nadav L, Eldor A, Yacoby-Zeevi O, Zamir E, Pecker I, Ilan N, Geiger B, Vlodavsky I, Katz BZ. Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 115:2179-2187, 2002.
23. Paulson DJ, Crass MF 3rd. Endogenous triacylglycerol metabolism in diabetic heart. Am J Physiol Heart Circ Physiol 242: H1084-H1094, 1982.
24. Pillarisetti S, Paka L, Sasaki A, Vanni-Reyes T, Yin B, Parthasarathy N, Wagner WD, Goldberg IJ. Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone. J Biol Chem 272: 15753-15759, 1997.
25. Pulinilkunnil T, Abrahani A, Varghese J, Chan N, Tang I, Ghosh S, Kulpa J, Allard M, Brownsey R, Rodrigues B. Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites. J Mol Cell Cardiol 35: 1093-1103, 2003.
26. Pulinilkunnil T, Qi D, Ghosh S, Cheung C, Yip P, Varghese J, Abrahani A, Brownsey R, Rodrigues B. Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining. Cardiovasc Res 59: 788 -797, 2003.
27. Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes 46: 1346-1353, 1997.
28. Ruge T, Bergo M, Hultin M, Olivecrona G, Olivecrona T. Nutritional regulation of binding sites for lipoprotein lipase in rat heart. Am J Physiol Endocrinol Metab 278: E211-E218, 2000.
29. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 266: 8162-8170, 1991.
30. Sambandam N, Abrahani MA, Craig S, Al-Atar O, Jeon E, Rodrigues B. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am J Physiol Heart Circ Physiol 278: H1874-H1882, 2000.
31. Sambandam N, Abrahani MA, St Pierre E, Al-Atar O, Cam MC, Rodrigues B. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin. Arterioscler Thromb Vasc Biol 19: 1526-1534, 1999.
32. Schubert SY, Ilan N, Shushy M, Ben-Izhak O, Vlodavsky I, Goldshmidt O. Human heparanase nuclear localization and enzymatic activity. Lab Invest 84: 535-544, 2004.
33. Scow RO, Blanchette-Mackie EJ. Endothelium, the dynamic interface in cardiac lipid transport. Mol Cell Biochem 116: 181-191, 1992.
34. Shafat I, Vlodavsky I, Ilan N. Characterization of mechanisms involved in secretion of active heparanase. J Biol Chem 281: 23804-23811, 2006.
35. Tong P, Khayat ZA, Huang C, Patel N, Ueyama A, Klip A. Insulin- induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles. J Clin Invest 108: 371-381, 2001.
36. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5: 793-802, 1999.
37. Vreys V, David G. Mammalian heparanase: what is the message? J Cell Mol Med 11: 427-452, 2007.
38. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848, 1991.
39. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 117:2249 -2258, 2004.